EMA Looks At New Ways To Define And Prioritize Unmet Pediatric Needs
Executive Summary
The European Medicines Agency is looking at new methodologies to define and prioritize unmet pediatric needs. Discussions on the use of a new scoring system are part of the agency’s “exploratory reflections”.
You may also be interested in...
‘Not What We Expected,’ R&D Industry Says Of ‘Onerous’ EU Paediatric Regulation
The research-based drug industry has not minced its words in describing the problems it has faced from the EU Paediatric Regulation over the past 10 years.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.